New patent expiration for Novartis Pharms drug ENTRESTO – DrugPatentWatch
Annual Drug Patent Expiration for ENTRESTO
Entresto is a drug marketed by Novartis Pharms Corp and included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.
ENTRESTO drug price trends.
Drug patent litigation for ENTRESTO.
This drug has thirty-six patent family members in twenty-seven countries.
The generic ingredient in ENTRESTO is sacubitril; valsartan. One registered supplier for this compound. Additional details are available on sacubitril; valsartan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in Recently expired patent for the drug Novartis Pharms ENTRESTO
